以肾脏交感神经射频消融术为代表的去肾脏交感神经治疗是顽固性高血压非药物治疗的新手段，进一步研究发现该技术同时可以治疗交感神经激活相关的其他疾病，如心功能不全、心房颤动和室性心律失常、呼吸睡眠暂停、胰岛素抵抗和蛋白尿，其广泛的应用前景使之成为心血管疾病治疗的新希望。

[1] ATHERTON D S,DEEP N L,MENDELSOHN F O.Micro-anatomy of the renal sympathetic nervous system:a human postmortem histologic study[J].Clin Anat,2012,25(5):628-633.
[2] 施蓓莉,倪兆慧.内皮素在慢性肾脏疾病及其心血管并发症中的作用.现代医学,2006,34(6):440-444.
[3] PARATI G, ESLER M.The human sympathetic nervous system:its relevance in hypertension and heart failure[J]. Eur Heart J, 2012,33:1058-1066.
[4] BERTOG S C,SOBOTKA P A,SIEVERT H.Renal denervation for hypertension[J].JACC Cardiovasc Interv,2012,5(3):249-258.
[5] KRUM H,SCHLAICH M,WHITBOURN R,et al.Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months[J].Hypertension,2011,57:911-917.
[6] ESLER M D, KRUM H, SOBOTKA P A.Symplicity HTN-2 Investigators et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial):a randomised controlled trial[J]. Lancet,2010,376:1903-1909.
[7] UKENA C,MAHFOUD F,KINDERMANN I,et al.Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension [J].J Am Coll Cardiol,2011,58(11):1176-1182.
[8] DIEZ J, QUEREJETA R, LOPEZ B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients[J]. Circulation,2002,105:2512-2517.
[9] BRANDT M C,MAHFOUD F,REDA S,et al.Renal sympathetic denervation reduces left ventricular hypertrophy and improve cardiac function in patients with resistant hypertension[J].J Am Coll Cardiol,2012,59(10):901-909.
[10] KANNEL W B, WOLF P A, BENJAMIN E J, et al.Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation:Population-based estimates[J]. Am J Cardiol,1998,82:2N-9N.
[11] BENJAMIN E J, CHEN P S, BILD D E, et al.Prevention of atrial fibrillation:report from a national heart, lung, and blood institute workshop[J]. Circulation,2009,119:606-618.
[12] SCHOTTEN U, VERHEULE S, KIRCHHOF P, et al.Pathophysiological mechanisms of atrial fibrillation:a translational appraisal[J]. Physiol Rev,2011,91:265-325.
[13] LAU D H, MACKENZIE L, KELLY D J, et al.Hypertension and atrial fibrillation:evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model[J]. Heart Rhythm,2010,7:1282-1290.
[14] SHEN M J, SHINOHARA T, PARK H W, et al.Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines[J]. Circulation,2011,123:2204-2212.
[15] POKUSHALOV F,ROMANOV A,CORBUCCI C,et al.A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denerationin patients with refractory symptomatic atrial fibrillation and resistant hypertension[J].J Am Coll Cardiol,2012,60:l 163.
[16] AHMED H,MILLER M A.Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study:clinical background and study design[J].J Cardiovasc Electrophysiol,2013,24(5):503-509.
[17] LOWN B, VERRIER R L.Neural activity and ventricular fibrillation[J]. N Engl J Med,1976,294:1165-1170.
[18] MAHFOUD F,SEHLAICH M,KINDERMANN I,et al.Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension:a pilot study[J].Circulation,2011,123(18):1940-1946.
[19] WITKOWSKI A,PREJBISZ A,FLOREZAK E,et al.Effects of renal sympathetic denervation on blood pressure,sleep apnea course,and glycemic control in patients with resistant hypertension and sleep apnea[J].Hypertension,2011,58 (4):559-565.
[20] SCHLAICH M P,HERING D,SOBOTKA P,et al.Effects of renal denervation on sympathetic activation,blood pressure,and glucose metabolism in patients with resistant hypertension[J].Front Physiol,2012,3:10.
[21] CALHOUN D A,JONES D,TEXTOR S,et al.Resistant hypertension:diagnosis,evaluation, and treatment.A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J].Circulation,2008,117(25):e510-e526.
[22] GRASSI G,FACCHINI A.Obstructive sleep apnea-dependent and-independent adrenergic activation in obesity[J]. Hypertension,2005,46(2):321-325.
[23] SOMERS V K, WHITE D P, AMIN R, et al. Sleep apnea and cardiovascular disease:an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing, in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)[J]. Circulation,2008,118:1080-1111.
[24] FRIEDMAN O, BRADLEY T D, CHAN C T, et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension[J]. Hypertension,2010,56:1077-1082.
[25] JOLES J A,KOOMANS H A.Causes and consequence of increased sympathetic activity in renal disease[J]. Hypertension,2004,43:699-706.
[26] ZHANG H,FABER J E.Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different α1-adrenoceptor subtypes[J].Circ Res,2001,89:815-822.
[27] MAHFOUD F, CREMERS B.Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension[J]. Hypertension,2012,60(2):419-424.
[28] KANDZARI D E,BHATT D L.Catheter-based renal denervation for resistant hypertension:rationale and design of the SYMPLICITY HTN-3 Trial[J]. Clin Cardiol,2012,35(9):528-535.
[29] VONEND O, ANTOCH G.Secondary rise in blood pressure after renal denervation[J]. Lancet,2012,380(9843):778.
[30] DI DANIELE N, FRANCESCO D E.Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient[J].Nephrol Dial Transplant,2012,27(4):1689-1690.
[31] WANG Q, GUO R. Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a preclinical canine model[J].J Am Coll Cardiol,2013,61(21):2185-2192.